logo
  • Home
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
  • Investors
    • Overview
    • News / Events
    • Shareholder Calls / Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact
    • Social Media Community Guidelines

Press Releases

Navigation Toggle Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Shareholder Calls / Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Feb 22, 2016

PharmaCyte Biotech Issues Update on Preparations for Its Pancreatic Cancer Clinical Trial

  • Feb 10, 2016

Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech

  • Feb 8, 2016

Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment

  • Jan 25, 2016

PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial

  • Jan 19, 2016

PharmaCyte Biotech Introduces Cell-in-a-Box as a Novel Treatment for Pancreatic Cancer and Potential Cure for Type 1 Diabetes

  • Jan 14, 2016

PharmaCyte Biotech Raises Additional $1 Million for Pancreatic Cancer Clinical Trial

  • Jan 7, 2016

PharmaCyte Biotech to Attend J.P. Morgan Healthcare Conference

  • Jan 4, 2016

PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial

  • Dec 30, 2015

PharmaCyte Biotech End of Year Shareholder Update on Pancreatic Cancer and Diabetes Programs

  • Dec 15, 2015

PharmaCyte Biotech Releases New Video Highlighting Diabetes Treatment Development Program

RSS
  • « Previous
  • 1...
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • ...29
  • Next »

Contact Us

PharmaCyte Biotech, Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

Latest News

  • PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan February 2, 2023
  • PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value October 7, 2022